- Home
- NBIX vs TXRH Comparison
NBIX vs TXRH Comparison
Compare NBIX & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- TXRH
- Stock Information
- Founded
- NBIX 1992
- TXRH 1993
- Country
- NBIX United States
- TXRH United States
- Employees
- NBIX N/A
- TXRH N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- TXRH Restaurants
- Sector
- NBIX Health Care
- TXRH Consumer Discretionary
- Exchange
- NBIX Nasdaq
- TXRH Nasdaq
- Market Cap
- NBIX 14.4B
- TXRH 10.7B
- IPO Year
- NBIX 1996
- TXRH 2004
- Fundamental
- Price
- NBIX $138.96
- TXRH $171.20
- Analyst Decision
- NBIX Strong Buy
- TXRH Buy
- Analyst Count
- NBIX 18
- TXRH 17
- Target Price
- NBIX $172.33
- TXRH $189.47
- AVG Volume (30 Days)
- NBIX 1.2M
- TXRH 1.2M
- Earning Date
- NBIX 10-28-2025
- TXRH 11-06-2025
- Dividend Yield
- NBIX N/A
- TXRH 1.59%
- EPS Growth
- NBIX 12.44
- TXRH 12.56
- EPS
- NBIX 4.19
- TXRH 6.55
- Revenue
- NBIX $2,682,700,000.00
- TXRH $5,833,958,000.00
- Revenue This Year
- NBIX $23.68
- TXRH $11.74
- Revenue Next Year
- NBIX $18.02
- TXRH $10.04
- P/E Ratio
- NBIX $33.07
- TXRH $26.10
- Revenue Growth
- NBIX 19.61
- TXRH 14.40
- 52 Week Low
- NBIX $84.23
- TXRH $148.73
- 52 Week High
- NBIX $157.67
- TXRH $206.04
- Technical
- Relative Strength Index (RSI)
- NBIX 41.83
- TXRH 55.49
- Support Level
- NBIX $145.00
- TXRH $165.73
- Resistance Level
- NBIX $148.84
- TXRH $169.79
- Average True Range (ATR)
- NBIX 5.03
- TXRH 4.85
- MACD
- NBIX -0.99
- TXRH 0.57
- Stochastic Oscillator
- NBIX 10.68
- TXRH 97.20
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.